Markets:

Overview

News

Currencies

International

Treasuries

Stryker Corp (NY:SYK)

318.60 +2.49 (+0.79%)

Streaming Delayed Price Updated: 9:30 AM EDT, Jun 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9

...

24 25 Next >

Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

April 13, 2026

From Stryker Corporation

Via GlobeNewswire

1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds

April 10, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...

Via StockStory

Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings?

April 09, 2026

Over the last six months, Stryker shares have sunk to $342.00, producing a disappointing 7.6% loss - worse than the S&P 500’s 1.8% drop. This may have invest...

Via StockStory

Topics Stocks Supply Chain

This Healthcare Stock Has No Debt and a Near-Monopoly in Its Market ↗

April 07, 2026

The company is a picture of financial stability.

Via The Motley Fool

Stryker Corp. (NYSE:SYK) Demonstrates a Balanced Profile for Dividend Investors ↗

March 25, 2026

Via Chartmill

Stryker Corp (NYSE:SYK): A Quality Dividend Growth Stock for Durable Income ↗

February 25, 2026

Via Chartmill

The Evolution of a MedTech Giant: A Deep Dive into Becton, Dickinson and Company (BDX)

April 01, 2026

As of April 1, 2026, Becton, Dickinson and Company (NYSE: BDX), commonly known as BD, finds itself at a historic crossroads. For decades, BD was viewed as a diversified healthcare conglomerate—a...

Via Finterra

Topics Economy Lawsuit Product Recall

Stryker to announce financial results for its first quarter of fiscal year 2026

April 01, 2026

From Stryker Corporation

Via GlobeNewswire

Stryker names Nick Mead Vice President, Investor Relations

March 31, 2026

Jason Beach appointed Vice President, Group CFO, MedSurg and Neurotechnology

From Stryker Corporation

Via GlobeNewswire

2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds

March 27, 2026

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are...

Via StockStory

Stryker announces Annual Meeting of Shareholders

March 23, 2026

From Stryker Corporation

Via GlobeNewswire

1 Oversold Stock Primed to Rebound and 2 We Question

March 19, 2026

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investo...

Via StockStory

Stocks making big moves yesterday: El Pollo Loco, Stryker, Dollar Tree, Coinbase, and Distribution Solutions

March 17, 2026

Check out the companies making headlines yesterday: El Pollo Loco (NASDAQ:LOCO): Fast food chain El Pollo Loco (NASDAQ:LOCO) rose by 5.4% on Monday after the...

Via StockStory

Stryker (SYK) Stock Is Up, What You Need To Know

March 16, 2026

What Happened? Shares of medical technology company Stryker (NYSE:SYK) jumped 3.2% in the afternoon session after investors appeared to buy the dip after the...

Via StockStory

Topics Economy Government World Trade

Stryker Corporation (SYK): Navigating Innovation and Resilience in the Wake of a Digital Crisis

March 16, 2026

As of March 16, 2026, the medical technology landscape is grappling with a stark reminder of the vulnerabilities inherent in the digital shift of healthcare. Stryker Corporation (NYSE: SYK), a global...

Via Finterra

Topics Earnings Economy Hacking

This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗

March 15, 2026

EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships.

Via The Motley Fool

This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗

March 15, 2026

This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide.

Via The Motley Fool

Topics Regulatory Compliance

Stryker Shipping Stock Slips As Cyberattack-Spurred Outage Drags On ↗

March 12, 2026

Bloomberg reported on Thursday that the company’s ordering and shipping systems are still offline following a cyberattack, claimed by pro-Iranian digital activist group Handala, on Wednesday.

Via Stocktwits

Topics Malware

Oracle Steals the Show as Oil Tensions Rattle Wall Street ↗

March 12, 2026

Via Chartmill

SYK Stock Slips On Report Of Global Outage Spurred By Suspected Iran-Linked Cyberattack ↗

March 11, 2026

The Wall Street Journal reported that the outage, which began after midnight on the East Coast, has had an impact across Stryker systems.

Via Stocktwits

Winners And Losers Of Q4: Stryker (NYSE:SYK) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

March 10, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices &...

Via StockStory

1 S&P 500 Stock with Solid Fundamentals and 2 We Turn Down

March 05, 2026

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...

Via StockStory

Topics Artificial Intelligence Intellectual Property Stocks

1 Profitable Stock to Keep an Eye On and 2 We Turn Down

February 25, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Medtronic Hits 10-Quarter High: PFA Dominance and Robotic Surges Signal a New Era for MedTech

February 23, 2026

In a definitive sign that the medical technology sector has moved past its post-pandemic stagnation, Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for the third...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape

February 19, 2026

On January 15, 2026, the medical technology sector witnessed its most significant seismic shift in years as Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire...

Via MarketMinute

Medtronic Hits Ten-Quarter Growth Peak in Q3 Fiscal 2026, Signaling Resurgence in MedTech Sector

February 19, 2026

Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for its fiscal third quarter of 2026, marking a significant turning point for the medical technology giant. The...

Via MarketMinute

Topics Artificial Intelligence Economy World Trade

Health Care Sector (XLV) Shows Resilience Amid Tech Volatility and Strong Jobs Data

February 18, 2026

As the broader market grappled with a violent valuation reset in the technology sector, the health care industry emerged as a critical anchor for investors in early 2026. The Health Care Select Sector...

Via MarketMinute

Topics Artificial Intelligence ETFs Earnings

Medtronic (MDT): The Sleeping Giant Awakes with Strong Q3 FY26 Momentum

February 17, 2026

Today’s Date: February 17, 2026 Introduction Medtronic plc (NYSE: MDT) has long been the sleeping giant of the medical technology sector. For years, the Dublin-domiciled powerhouse was viewed by Wall...

Via Finterra

Topics Artificial Intelligence Earnings Economy

The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition

February 05, 2026

In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for...

Via MarketMinute

Topics Supply Chain

Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)

February 05, 2026

February 5, 2026 The medical technology landscape experienced a seismic shift this week as one of its long-standing titans, Boston Scientific (NYSE: BSX), faced a "valuation reset" that has left...

Via Finterra

Topics Product Recall World Trade

< Previous 1 2 3 4 5 6 7 8 9

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.